Annelle Onishi, MD
Family Medicine · Kihei, HINPI 1295825750
Payments from drug & device makers
What this record shows
This record is dominated by gifts: $7,942 of the $9,728 with a category attached, or 81.6%. AbbVie accounts for 83.0% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2019 at $8,065 and has fallen 96.4% since, to $288 in 2025. Among family medicine clinicians in HI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 98 payments — averaging $99.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$8K
- Amgen$658
- Otsuka America Pharmaceutical, Inc.$152
- Novartis$141
- Astellas Pharma US Inc$98
- GSK$85
- plus $517 from 20 others
What the payments were for
- Food & beverage$1,78618%
- Gifts$7,94282%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 9 | $8,077 |
| Amgen(2 entities) | 31 | $658 |
| Otsuka America Pharmaceutical, Inc. | 11 | $152 |
| Novartis | 7 | $141 |
| Astellas Pharma US Inc | 4 | $98 |
| GSK | 5 | $85 |
| Boehringer Ingelheim | 3 | $77 |
| Lilly USA, LLC | 4 | $56 |
| Arbor Pharmaceuticals, Inc. | 3 | $50 |
| Merck | 3 | $39 |
| AstraZeneca | 2 | $32 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $29 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Eisai Inc. | 1 | $24 |
| Sanofi Pasteur Inc. | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Novo Nordisk | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Johnson & Johnson | 1 | $16 |
| Medtronic | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Corcept Therapeutics | 1 | $12 |
| Sonex Health, Inc. | 1 | $12 |
| Sanofi-aventis U.S. LLC | 1 | $11 |
| Melinta Therapeutics, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX COSMETIC$7,942
How this compares
$9,728 in reported general payments places this provider in the 95th percentile of 376 family medicine providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 20 | $28,248 |
| EliquisApixaban | 26 | $21,755 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $7,919 |
| Memantine Hcl ErMemantine Hcl | 15 | $1,118 |
| Levothyroxine Sodium | 75 | $938 |
| Gabapentin | 40 | $691 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 29 | $680 |
| Metoprolol Succinate | 61 | $669 |
| ValacyclovirValacyclovir Hcl | 16 | $516 |
| Rosuvastatin Calcium | 30 | $490 |
| Estradiol (Twice Weekly)Estradiol | 12 | $488 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $488 |
| Oxybutynin Chloride ErOxybutynin Chloride | 12 | $455 |
| Celecoxib | 34 | $448 |
| Losartan Potassium | 51 | $444 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $56 | $28,24820 claims |
| GSKTrelegy Ellipta | $85 | $7,91912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 376 family medicine providers in Hawaii.
Other family medicine in Kihei
- Brian StolleyKihei$126K
- Heather BejenaruKihei$7K
- Burton FeinermanKihei$3K
- Vicente RamoHonolulu$34K
- Edward AlqueroWaipahu$24K
- Noelani HobbsWaipahu$23K
- Rainier Dennis BautistaLihue$23K
- Choon YeoHonolulu$20K
- Buddy FesterlingHilo$20K
- Roy KogaHilo$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.